CNTB: 康乃德生物
今日CNTB汇率已更改-2.70%。当日,交易品种以低点2.15和高点2.40进行交易。
关注康乃德生物动态。实时报价将帮助您快速应对市场变化。通过在不同的时间周期之间切换,您可以按分钟、小时、天、周和月监控汇率趋势和动态。使用这些信息来预测市场变化并做出明智的交易决策。
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
CNTB新闻
- Connect Biopharma Holdings Limited (CNTB) Discusses Development Strategy for Next-Generation Biologic Targeting Acute and Chronic Respiratory Diseases Transcript
- BTIG 因呼吸系统药物潜力给予 Connect Biopharma 股票"买入"评级
- Connect Biopharma stock initiated with Buy rating at BTIG on respiratory drug potential
- This Immuneering Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday - Connect Biopharma Hldgs (NASDAQ:CNTB), Immuneering (NASDAQ:IMRX)
- H.C. Wainwright维持Connect Biopharma股票买入评级,目标价7美元
- H.C. Wainwright reiterates Buy rating on Connect Biopharma stock at $7 target
- Connect Biopharma Posts Q2 Revenue Drop
- What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
- Connect Biopharma stock rating reiterated as Outperform by Northland
- Connect Biopharma appoints Jim Schoeneck to board of directors
- Connect Biopharma appoints James A. Schoeneck to board of directors
- Connect Biopharma stock rises after announcing plan to terminate ADR program
- Connect Biopharma to terminate ADR program, list ordinary shares
- Connect Biopharma regains Nasdaq compliance with minimum bid price rule
- Connect Biopharma regains Nasdaq compliance with $1 minimum bid price
- Connect Biopharma’s partner submits new drug application in China
- Connect Biopharma reports positive data for asthma treatment
- Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
- Connect Biopharma to Present at Two Upcoming Investor Conferences in June
- Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
- Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
- Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD
常见问题解答
CNTB股票今天的价格是多少?
康乃德生物股票今天的定价为2.16。它在2.15 - 2.40范围内交易,昨天的收盘价为2.22,交易量达到262。CNTB的实时价格图表显示了这些更新。
康乃德生物股票是否支付股息?
康乃德生物目前的价值为2.16。股息政策取决于公司,而投资者也会关注122.68%和USD。实时查看图表以跟踪CNTB走势。
如何购买CNTB股票?
您可以以2.16的当前价格购买康乃德生物股票。订单通常设置在2.16或2.46附近,而262和-4.00%显示市场活动。立即关注CNTB的实时图表更新。
如何投资CNTB股票?
投资康乃德生物需要考虑年度范围0.51 - 3.28和当前价格2.16。许多人在以2.16或2.46下订单之前,会比较-23.67%和。实时查看CNTB价格图表,了解每日变化。
康乃德生物股票的最高价格是多少?
在过去一年中,康乃德生物的最高价格是3.28。在0.51 - 3.28内,该股波动显著,与相比有助于发现阻力位。使用实时图表跟踪康乃德生物的绩效。
康乃德生物股票的最低价格是多少?
康乃德生物(CNTB)的最低价格为0.51。将其与当前的2.16和0.51 - 3.28进行比较,可以发现潜在的长期切入点。观看CNTB在图表上的实时走势以获取更多详细信息。
CNTB股票是什么时候拆分的?
康乃德生物历史上曾经历过股票拆分。这些变化在公司行动后的、2.22和122.68%中可见。
- 前一天收盘价
- 2.22
- 开盘价
- 2.25
- 卖价
- 2.16
- 买价
- 2.46
- 最低价
- 2.15
- 最高价
- 2.40
- 交易量
- 262
- 日变化
- -2.70%
- 月变化
- -23.67%
- 6个月变化
- 7.46%
- 年变化
- 122.68%
- 实际值
- 预测值
- 前值